The role of vitamin D in the prevention and treatment of selected autoimmune diseases
DOI:
https://doi.org/10.12775/JEHS.2025.85.66902Keywords
'vitamin D, autoimmune diseases, pathogenesis, Rheumatoid arthritis, Multiple Sclerosis, Systemic Lupus Erythematosus, Supplementation, TreatmentAbstract
Background. Autoimmune diseases affect a large number of people worldwide and currently pose a serious challenge to public health. Growing knowledge about their epidemiology, risk factors, as well as the processes leading to their development and the mechanisms responsible for their onset, opens new possibilities for the prevention and treatment of these diseases.
Aim. The article aims to draw attention to vitamin D and its powerful immunomodulatory effect, which is attracting increasing interest in the potential regulation of the immune response and its use in the prevention and treatment of autoimmune diseases.
Material and Methods. A literature review has been conducted using databases such as PubMed. Particular attention was paid to the most recent years of publication.
Conclusions. Vitamin D supplementation in people with autoimmune disease can provide numerous benefits, such as paincontrol, fatigue reduction, lower disease activity scores, remission induction, and reduced need for other medications. According to many premises, the active form of vitamin D may be a useful parameter in monitoring inflammation, a therapeutic biomarker, and even an indicator of disease progression and treatment effectiveness. However, further researchis needed to assess the long-term effects and to gain a more complete understanding of the role, mechanisms ofaction and safety profile of vitamin D supplementation. Until more conclusive evidence is available, vitamin D should be considered only as a potentially helpful adjunct in the prevention and treatment of autoimmune diseases.
References
[1] Song, Y., Li, J., C Wu, Y. (2024). Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders. Signal transduction and targeted therapy, S(1), 263. https://doi.org/10.1038/s41392-024-01952-8
[2] Athanassiou, L., Kostoglou-Athanassiou, I., Koutsilieris, M., C Shoenfeld, Y. (2023). Vitamin D and autoimmune rheumatic diseases. Biomolecules, 13(4), 709. https://doi.org/10.3390/biom13040709
[3] Pludowski P. (2023). Vitamin D supplementation in different patient groups to reduce deficiencies. Nutrients, 15(17), 3725. https://doi.org/10.3390/nu15173725
[4] Ranjbar M, Rahimlou M, Fallah M, Djafarian K, Mohammadi H. Effects of vitamin D supplementation in patients with rheumatoid arthritis: A systematic review and meta-analysis. Heliyon. 2025;11(3):e42463. Published 2025 Feb 4. https://doi.org/10.1016/j.heliyon.2025.e42463
[5] Skrobot A, Demkow U, Wachowska M. Immunomodulatory Role of Vitamin D: A Review. Adv Exp Med Biol. 2018;1108:13-23. https://doi.org/10.1007/5584_2018_246
[6] Chambers ES, Hawrylowicz CM. The impact of vitamin D on regulatory T cells. Curr Allergy Asthma Rep. 2011;11(1):29-36. https://doi.org/10.1007/s11882-010-0161-8
[7] Harrison SR, Li D, Jeffery LE, Raza K, Hewison M. Vitamin D, Autoimmune Disease and Rheumatoid Arthritis. Calcif Tissue Int. 2020;106(1):58-75. https://doi.org/10.1007/s00223-019-00577-2
[8] Fassio A, Gatti D, Rossini M, et al. Effects on Serum Inflammatory Cytokines of Cholecalciferol Supplementation in Healthy Subjects with Vitamin D Deficiency. Nutrients. 2022;14(22):4823. Published 2022 Nov 14. https://doi.org/10.3390/nu14224823
[9] Mu S, Wang W, Liu Q, et al. Autoimmune disease: a view of epigenetics and therapeutic targeting. Front Immunol. 2024;15:1482728. Published 2024 Nov 13. https://doi.org/10.3389/fimmu.2024.1482728
[10] Hasan, Ahmed & Raheem, Hasan & K. Hameed, Alaa. (2022). Rheumatic autoimmune diseases (focus on RA) : prevalence, types, causes and diagnosis.
[11] Radu AF, Bungau SG. Management of Rheumatoid Arthritis: An Overview. Cells. 2021;10(11):2857. Published 2021 Oct 23. https://doi.org/10.3390/cells10112857
[12] Rexhepi M, Krasniqi B, Hoti K, Daci A, Rexhepi-Kelmendi B, Krasniqi S. Impact of vitamin D supplementation on disease activity and pain management in rheumatoid arthritis: a randomized double-blinded controlled study. BMC Rheumatol. 2025;9(1):87. Published 2025 Jul 11. https://doi.org/10.1186/s41927-025-00543-6
[13] Al-Saoodi H, Kolahdooz F, Andersen JR, Jalili M. Effect of vitamin D on inflammatory and clinical outcomes in patients with rheumatoid arthritis: a systematic review and dose-response meta-analysis of randomized controlled trials. Nutr Rev. 2024;82(5):600-611. https://doi.org/10.1093/nutrit/nuad083
[14] Low CE, Loke S, Chew NSM, Lee ARYB, Tay SH. Vitamin, antioxidant and micronutrient supplementation and the risk of developing incident autoimmune diseases: a systematic review and meta-analysis. Front Immunol. 2024;15:1453703. Published 2024 Dec 9. https://doi.org/10.3389/fimmu.2024.1453703
[15] Song GG, Bae SC, Lee YH. Association between vitamin D intake and the risk of rheumatoid arthritis: a meta-analysis. Clin Rheumatol. 2012;31(12):1733–9. https://doi.org/10.1007/S10067-012-2080-7.
[16] Serag I, Abouzid M, Alsaadany KR, et al. Role of vitamin D as adjuvant therapy on multiple sclerosis: an updated systematic review and meta-analysis of randomized controlled trials. Eur J Med Res. 2025;30(1):736. Published 2025 Aug 12. https://doi.org/10.1186/s40001-025-02981-x
[17] Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O. Multiple sclerosis. Lancet. 2018;391(10130):1622-1636. https://doi.org/10.1016/S0140-6736(18)30481-1
[18] Haki M, Al-Biati HA, Al-Tameemi ZS, Ali IS, Al-Hussaniy HA. Review of multiple sclerosis: Epidemiology, etiology, pathophysiology, and treatment. Medicine (Baltimore). 2024;103(8):e37297. https://doi.org/10.1097/MD.0000000000037297
[19] Correale J, Ysrraelit MC, Gaitán MI. Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain. 2009;132(Pt 5):1146-1160. doi:10.1093/brain/awp033
[20] Galoppin M, Kari S, Soldati S, et al. Full spectrum of vitamin D immunomodulation in multiple sclerosis: mechanisms and therapeutic implications. Brain Commun. 2022;4(4):fcac171. Published 2022 Jun 30. https://doi.org/10.1093/braincomms/fcac171
[21] Mowry EM, Waubant E, McCulloch CE, et al. Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis. Ann Neurol. 2012;72(2):234-240. https://doi.org/10.1002/ana.23591
[22] Montini F, Nozzolillo A, Tedone N, et al. COVID-19 has no impact on disease activity, progression and cognitive performance in people with multiple sclerosis: a 2-year study. J Neurol Neurosurg Psychiatry. 2024;95(4):342-347. Published 2024 Mar 13. https://doi.org/10.1136/jnnp-2023-332073
[23] El Kababi S, El Ouali EM, Kartibou J, Lamiri A, Deblij S, Supriya R, Saiedi A, Del Coso J, Laher I, Zouhal H. A Systematic Review and Meta-Analysis of the Effects of Vitamin D on Systemic Lupus Erythematosus. Nutrients. 2025; 17(17):2794. https://doi.org/10.3390/nu17172794
[24] Accapezzato D, Caccavale R, Paroli MP, et al. Advances in the Pathogenesis and Treatment of Systemic Lupus Erythematosus. Int J Mol Sci. 2023;24(7):6578. Published 2023 Mar 31. https://doi.org/10.3390/ijms24076578
[25] Schilirò D, Silvagni E, Ciribè B, et al. Systemic lupus erythematosus: one year in review 2024. Clin Exp Rheumatol. 2024;42(3):583-592. https://doi.org/10.55563/clinexprheumatol/mnvmvo
[26] Irfan SA, Ali AA, Shabbir N, et al. Effects of Vitamin D on Systemic Lupus Erythematosus Disease Activity and Autoimmunity: A Systematic Review and Meta-Analysis. Cureus. 2022;14(6):e25896. Published 2022 Jun 13. https://doi.org/10.7759/cureus.25896
[27] Arshad A, Mahmood SBZ, Ayaz A, Al Karim Manji A, Ahuja AK. Association of vitamin D deficiency and disease activity in systemic lupus erythematosus patients: Two-year follow-up study. Arch Rheumatol. 2020;36(1):101-106. Published 2020 Dec 10. https://doi.org/10.46497/ArchRheumatol.2021.8178
[28] Mukherjee D, Lahiry S, Thakur S, Chakraborty DS. Effect of 1,25 dihydroxy vitamin D3 supplementation on pain relief in early rheumatoid arthritis. J Family Med Prim Care. 2019;8(2):517-522. https://doi.org/10.4103/jfmpc.jfmpc_446_18
[29] Singgih Wahono C, Diah Setyorini C, Kalim H, Nurdiana N, Handono K. Effect of Curcuma xanthorrhiza Supplementation on Systemic Lupus Erythematosus Patients with Hypovitamin D Which Were Given Vitamin D3 towards Disease Activity (SLEDAI), IL-6, and TGF-β1 Serum. Int J Rheumatol. 2017;2017:7687053. https://doi.org/10.1155/2017/7687053
[30] Jiang LJ, Rong ZH, Zhang HF. The changes of Treg and Th17 cells relate to serum 25(OH)D in patients with initial-onset childhood systemic lupus erythematosus. Front Pediatr. 2023;11:1228112. Published 2023 Aug 23. https://doi.org/10.3389/fped.2023.1228112
[31] Thouvenot E, Laplaud D, Lebrun-Frenay C, et al. High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial. JAMA. 2025;333(16):1413-1422. https://doi.org/10.1001/jama.2025.1604
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Aleksandra Beata Chojnacka, Jacek Borawski, Julia Burdon-Sajnóg, Zofia Szymona-Kuciewicz, Klaudia Katarzyna Bartela, Julia Katarzyna Dusiel, Anna Wałachowska, Alicja Tabian, Paulina Kozłowska, Jakub Smęt

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 47
Number of citations: 0